Company & Sponsor Intelligence
Yale University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials30
Recruiting9
Completed19
Countries3
Therapeutic footprint
adhdalzheimersautismdepressioneating_disordersneurodevelopmental_otherocdother_neurologyother_psychiatryparkinsonsptsdschizophreniasubstance_use
Indexed studies
NCT01917864iPad Application to Treat Prosodic Deficits in Students With Communication Disorders
autism · United StatesNA
autism · United StatesNA
NCT06996652An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
parkinsons · United StatesPHASE2
parkinsons · United StatesPHASE2
NCT05109507Single-Session Intervention Targeting Emotional Awareness, Clarity, and Acceptance to Reduce Depression/Anxiety
depression · United StatesNA
depression · United StatesNA
NCT04936009Transcranial Magnetic Stimulation (TMS) Study for Adults With Autism Spectrum Disorder (ASD)
autism · United StatesNA
autism · United StatesNA
NCT00291226Glycine vs Placebo for the Schizophrenia Prodrome
schizophrenia · United StatesPHASE2, PHASE3
schizophrenia · United StatesPHASE2, PHASE3
NCT05495997Cognitive Training in Parkinson's Disease
parkinsons · United StatesNA
parkinsons · United StatesNA
NCT02419313Investigation of the Efficacy and Safety of IncobotulinumtoxinA (Xeomin) in Parkinson's Tremor: A Customized Approach
parkinsons · United StatesPHASE2
parkinsons · United StatesPHASE2
NCT01719523Open-Trial of EPI-743 for Adults With Tourette Syndrome
neurodevelopmental_other · United StatesPHASE1
neurodevelopmental_other · United StatesPHASE1
NCT04131829Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
ocd · United StatesPHASE1, PHASE2
ocd · United StatesPHASE1, PHASE2
NCT07449351Psilocybin Microdosing on Cognition, Mood and Quality of Life
other_neurology · United StatesEARLY_PHASE1
other_neurology · United StatesEARLY_PHASE1
NCT04711915Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
depression · United StatesPHASE1
depression · United StatesPHASE1
NCT02488226Gaze Modification Strategies for Toddlers With Autism Spectrum Disorder
autism · United StatesNA
autism · United StatesNA
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →